12:00 AM
 | 
Dec 16, 2002
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Genzyme General

(GENZ), Cambridge, Mass.

Business: Biopharmaceuticals

Fortis Bank analyst Geraldine O'Keeffe raised her price target to $42 from...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >